Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

SCM Pharma

SCM Pharma is a contract development & manufacturing organisation (CDMO) that develops and makes novel, difficult and dangerous drugs on behalf of our clients. Our formulation development, cGMP manufacturing and aseptic processing services include the sterile filling of liquids, gels and powders (including flammable products) into a range of final dosage forms including ampoules, vials, cartridges, syringes and bottles. So if you’re a pharmaceutical, biotech, medical device or healthcare institution in need of formulation development, clinical manufacturing or contract filling involving a complex product or process – let’s talk.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

SCM Pharma
Unit 6 Regents Drive, Low Prudhoe Industrial Estate, Prudhoe, Northumberland, NE42 6PX, United Kingdom
+44(0) 1661 833 693
Contact SCM Pharma
Website

 Latest Content from PMHub 

Accelerating patient recruitment in clinical trials post COVID-19

Videos and Podcasts | June 13, 2022 | Innovative Trials

Patient recruitment is arguably one of the most important aspects of a clinical trial. Without enough participants, trials will inevitably fail, meaning potentially effective therapies will not be brought to...

Diversity in Clinical Trials: A more inclusive approach in patient recruitment

Videos and Podcasts | June 13, 2022 | Innovative Trials

We have seen a growing focus on patient diversity in clinical trials in recent years, but the COVID-19 vaccine trials in particular have highlighted the importance of achieving diverse patient...

Part 4 of 4, of the Medscape video interview series

Videos and Podcasts | June 10, 2022 | Medscape Education

Dr. Hansa Bhargava MD interviews Dr. Maria Victoria Mateos on the most important abstracts to look out for in multiple myeloma and the potential implications of these data for managing patients...

How whole genome sequencing is revolutionising the rare disease patient experience

White Papers and Resources | June 10, 2022 | IGNIFI

In this white paper, we discuss how whole genome sequencing (WGS) projects and the data sets they produce are paving the way for developments in research, diagnosis, and early interventions...

The Future of MedTech: Streamlined Clinical Data Collection & Management

Videos and Podcasts | June 9, 2022 | Impetus Digital

Jón Ingi Bergsteinsson, Co-founder & CCO at SMART-TRIAL, explores the barriers to, and benefits of, digitalization of clinical operations and trials in the MedTech industry, plus much more!

Bedrock mark International Batten Disease Awareness Day 2022 with Noah’s Story

Press Releases | June 9, 2022 | Resonant Group

Emily Wigginton, Bedrock’s Head of Client Services, explains the inspiration behind the film designed to bring more awareness to the public about rare disease.

Innovative Trials partners with MS Society

Press Releases | June 7, 2022 | Innovative Trials

UK-based patient recruitment company announces its annual charity partnership in support of multiple sclerosis

Digital Opinion Leaders (DOLs): Who are they and how can Pharma engage them?

White Papers and Resources | June 6, 2022 | Impetus Digital

With our growing dependence on social media, Digital Opinion Leaders are becoming an increasingly important stakeholder group for Pharma teams to engage and consult. But who are these DOLs, and...

Part 3 of the Medscape video series #EHA

Videos and Podcasts | June 6, 2022 | Medscape Education

Ahead of  Europe’s largest hematology conference Hansa Bhargava MD, Medscape Education Chief Medical Officer, interviews Dr. Naval Daver on the most important abstracts to look out for in Myeloid and...

Part 2 of the Medscape video interview series

Videos and Podcasts | June 6, 2022 | Medscape Education

Ahead of Europe’s largest haematology conference Hansa Bhargava MD, Medscape Education Chief Medical Officer interviews Dr. John Gribben on the most important abstracts to look out for in CLL and the...